(Q40375540)

19 September 2017

title

Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatin (English)

1 reference

19 September 2017

0 references

Siyaram Pandey

1

1 reference

19 September 2017

Natasha Kekre

series ordinal

2

1 reference

19 September 2017

Jafar Naderi

series ordinal

3

1 reference

19 September 2017

James McNulty

series ordinal

4

1 reference

19 September 2017

publication date

1 January 2005

1 reference

Artificial Cells, Blood Substitutes, and Biotechnology

19 September 2017

published in

1 reference

19 September 2017

volume

33

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

279-295

1 reference

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Programmed cell death: many ways for cells to die decently.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Anticancer therapy targeting the apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

TRAIL/Apo-2L: mechanisms and clinical applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Taxanes: the genetic toxicity of paclitaxel and docetaxel in somatic cells of Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Interaction of dolastatin 10 with bovine brain tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Antineoplastic agents, 256. Cell growth inhibitory isocarbostyrils from Hymenocallis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Oxidative stress-induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and over-expression of Bax: resistance of quiescent cells to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Inhibition of cell cycle progression through specific phase by pancratistatin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Apoptosis-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells; inhibition of cell death by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

Inhibition of bcl-2 as cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIO-200066621

21 January 2018

Identifiers

DOI

10.1081/BIO-200066621

1 reference

19 September 2017

1 reference